Curaleaf Holdings (CURLF) Depreciation & Amortization (CF) (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Depreciation & Amortization (CF) of $73.1 million for Q4 2024, up 42.3% year-on-year from $51.4 million in Q1 2024, and up 33.88% on a QoQ basis from $54.6 million in Q3 2024.

Curaleaf Holdings (CURLF) Depreciation & Amortization (CF) (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $73.1 million the latest figure, recorded in Q4 2024.

  • Quarterly Depreciation & Amortization (CF) rose 42.3% year-over-year to $73.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $73.1 million (down 31.02% YoY) and the FY2025 annual result came in at $196.6 million, down 15.06% from the prior year.
  • Depreciation & Amortization (CF) advanced to $73.1 million in Q4 2024 per CURLF's latest filing, from $54.6 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for CURLF reached as high as $73.1 million in Q4 2024 and fell as low as $14.9 million in Q1 2020.
  • A 5-year average of $36.4 million and a median of $33.7 million in 2021 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 86.24% — and 2022, when it decreased 19.13%.
  • Year by year, Depreciation & Amortization (CF) stood at $20.2 million in 2020, then grew by 25.47% to $25.4 million in 2021, then jumped by 73.66% to $44.1 million in 2022, then climbed by 16.55% to $51.4 million in 2023, then jumped by 42.3% to $73.1 million in 2024.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $73.1 million, $54.6 million, and $51.4 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 73.12 Mn
Dec 31, 2024 73.12 Mn
Sep 30, 2024 54.61 Mn
Sep 30, 2024 54.61 Mn
Dec 31, 2023 51.38 Mn
Dec 31, 2023 51.38 Mn
Sep 30, 2023 47.28 Mn
Sep 30, 2023 47.28 Mn
Dec 31, 2022 44.09 Mn
Dec 31, 2022 44.09 Mn
Sep 30, 2022 28.23 Mn
Sep 30, 2022 28.23 Mn
Jun 30, 2022 42.82 Mn
Jun 30, 2022 42.82 Mn
Mar 31, 2022 40.84 Mn
Mar 31, 2022 40.84 Mn
Dec 31, 2021 25.39 Mn
Dec 31, 2021 25.39 Mn
Sep 30, 2021 34.91 Mn
Sep 30, 2021 34.91 Mn